BRAS Workshop on Registries, observational studies and ...
BRAS Workshop on Registries, observational studies and the challenges of data gathering for drug reimbursement purposes
Novotel Brussels Airport, December 4th 2014
The session is organized for persons involved in Regulatory Affairs, Market Access / Pricing and Reimbursement.
The course is intended to provide a basic knowledge and understanding of the main principles and key dynamics related with the use of registries and observational studies in a Belgian context.
There is an ever increasing demand for gathering (real life) data within the scope of drug reimbursement. Registries and observational studies need to be set up; which leads to an increased complexity and has a considerable impact on all parties (companies, physicians, government & payers) involved.
A panel of experts will guide you on an interactive way through the various practical aspects of the set-up. The actual and future developments on the proper use of registries and observational studies will be highlighted and help you to gain insight into the different stakeholders view.
Participants will, prior to the course day, have the opportunity to submit their general questions or specific cases which we will submit to the experts for potential integration in their lecture.
This one day BRAS workshop will take place on Thursday 4 December 2014 at the Novotel Brussels Airport, 1831 Diegem, from 10h00 to 16h00.
The language for the workshop is Dutch and French.
The course is open to anyone interesting in learning, but in order to grant the participants the best teaching quality, the attendance is limited. Therefore, if you are interested in following the course, early registration is recommended.
Programme and Speakers:
09h30 Registration and coffee
10h00 Welcome & introduction to the course
Anne Bruneel & Leen De Paepe, BRAS Market Access Working Group
10h15 Real world data in the Belgian Pharmaceutical reimbursement setting
Vera Bormans & Philippe Van Wilder, SMART & BI, Access to Health Care
11h00 Coffee break
11h30 Healthdata.be: Harmonization of data collection and management of Belgian research registries public health and health care.
Johan Van Bussel, WIV-ISP Healthdata.be, Head of Service
12h15 Data gathering: the perspective of a clinical scientist
René Westhovens, MD PhD Rheumatologist KU Leuven
14h00 Data gathering: the objectives and mission of IMA-AIM. A practical approach
Joeri Guillaume, Program Manager IMA-AIM; Senior medewerker studiedienst Nationaal Verbond van Socialistische Mutualiteiten (NVSM)
15h00 Coffee break
15h30 Real world evidence (RWE) in market access: European perspective
Philippe Van Wilder, VUB, Dept. of Clin. Pharmacology and Pharmacotherapy
16h30 End of the session
Fees: 450€ for BRAS members - 550€ for non-BRAS members